<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-04-13</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38610954/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38610954-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite decades of research and the best up-to-date treatments, grade 4 Glioblastoma (GBM) remains uniformly fatal with a patient median overall survival of less than 2 years. Recent advances in immunotherapy have reignited interest in utilizing immunological approaches to fight cancer. However, current immunotherapies have so far not met the anticipated expectations, achieving modest results in their journey from bench to bedside for the treatment of GBM. Understanding the intrinsic features &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38610956/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38610956-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A multidisciplinary approach to the management of tongue cancer is vital for achieving optimal patient outcomes. Nursing and allied health professionals play essential roles within the team. We developed symposia comprising a series of online lectures offering a detailed perspective on the role each discipline and consumer perspective has in the management of patients with tongue cancer. The topics, including epidemiology and prevention, diagnosis, treatment planning, surgery, adjuvant care, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38610957/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Factors Impacting Microwave Ablation Zone Sizes: A Retrospective Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38610957-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Larger AZVs can be expected in cases of HCCs compared with metastases and in non-perivascular locations. Using the &lsquo;surgical mode&rsquo; does not increase AZV &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38610958/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38610958-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Total neoadjuvant therapy (TNT) is an evolving treatment schedule for locally advanced rectal cancer (LARC), allowing for organ preservation in a relevant number of patients in the case of complete response. Patients who undergo this so-called &ldquo;watch and wait&rdquo; approach are likely to benefit regarding their quality of life (QoL), especially if definitive ostomy could be avoided. In this work, we performed the first cost-effectiveness analysis from the patient perspective to compare costs for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38610966/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38610966-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    B cell acute lymphoblastic leukemia (B-ALL) is characterized by an accumulation of malignant precursor cells. Treatment consists of multiagent chemotherapy followed by allogeneic stem cell transplantation in high-risk patients. In addition, patients bearing the BCR-ABL1 fusion gene receive concomitant tyrosine kinase inhibitor (TKI) therapy. On the other hand, monoclonal antibody therapy is increasingly used in both clinical trials and real-world settings. The introduction of rituximab &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38611018/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38611018-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Ir-hypophysitis reveals different clinical pictures and onset times depending on the ICI regime used. Whereas a drop in T4 levels was indicative of developing hypophysitis independent of the ICI regime, TSH levels only declined in patients under ipilimumab-based ICI regimes. To best monitor our patients, it is important to recognize these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38611033/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Functional Classification of Fusion Proteins in Sarcoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38611033-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Sarcomas comprise a heterogeneous group of malignant tumors of mesenchymal origin. More than 80 entities are associated with different mesenchymal lineages. Sarcomas with fibroblastic, muscle, bone, vascular, adipocytic, and other characteristics are distinguished. Nearly half of all entities contain specific chromosomal translocations that give rise to fusion proteins. These are mostly pathognomonic, and their detection by various molecular techniques supports histopathologic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38611655/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38611655-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In this proof-of-concept study, we show that PD-L1 can be detected in the urine of RCC patients. Urine PD-L1 levels were found to correlate with the treatment response in mRCC patients and were significantly elevated in treatment-naÃ¯ve RCC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38611899/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4&lt;em&gt;H&lt;/em&gt;-tetrahydro-thiopyran-4-one &lt;em&gt;S&lt;/em&gt;-Oxides: Their Interplay in a Cascade of Redox Reactions from Diarylideneacetones</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38611899-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    2,6-Diaryl-4H-tetrahydro-thiopyran-4-ones and corresponding sulfoxide and sulfone derivatives were designed to lower the major toxicity of their parent anti-kinetoplatidal diarylideneacetones through a prodrug effect. Novel diastereoselective methodologies were developed and generalized from diarylideneacetones and 2,6-diaryl-4H-tetrahydro-thiopyran-4-ones to allow the introduction of a wide substitution profile and to prepare the related S-oxides. The in vitro biological activity &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612497/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Fibrin Glue Coating Limits Scar Tissue Formation around Peripheral Nerves</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612497-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Scar tissue formation presents a significant barrier to peripheral nerve recovery in clinical practice. While different experimental methods have been described, there is no clinically available gold standard for its prevention. This study aims to determine the potential of fibrin glue (FG) to limit scarring around peripheral nerves. Thirty rats were divided into three groups: glutaraldehyde-induced sciatic nerve injury treated with FG (GA + FG), sciatic nerve injury with no treatment (GA), &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612596/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">The Dual Role of Neutrophil Extracellular Traps (NETs) in Sepsis and Ischemia-Reperfusion Injury: Comparative Analysis across Murine Models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612596-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A better understanding of the function of neutrophil extracellular traps (NETs) may facilitate the development of interventions for sepsis. The study aims to investigate the formation and degradation of NETs in three murine sepsis models and to analyze the production of reactive oxygen species (ROS) during NET formation. Murine sepsis was induced by midgut volvulus (720Â° for 15 min), cecal ligation and puncture (CLP), or the application of lipopolysaccharide (LPS) (10 mg/kg body weight &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612652/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612652-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systemic sclerosis (SSc), a predominantly female-affected systemic autoimmune disease, requires tailored treatment strategies contingent on organ involvement and symptom severity. Given SSc&rsquo;s inflammatory nature, the involvement of the kynurenine pathway (KP) in its pathophysiology is underexplored. Our study aimed to investigate sex-related differences in KP activation among SSc patients and assess the impact of angiotensin-converting enzyme (ACE) inhibitors and estimated glomerular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612799/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612799-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    EGFR exon 20 (EGFR Ex20) insertion mutations in non-small cell lung cancer (NSCLC) are insensitive to traditional EGFR tyrosine kinase inhibitors (TKIs). Mobocertinib is the only approved TKI specifically designed to target EGFR Ex20. We performed an international, real-world safety and efficacy analysis on patients with EGFR Ex20-positive NSCLC enrolled in a mobocertinib early access program. We explored the mechanisms of resistance by analyzing postprogression biopsies, as well &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612927/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612927-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Drug efflux transporters of the ATP-binding-cassette superfamily play a major role in the availability and concentration of drugs at their site of action. ABCC2 (MRP2) and ABCG2 (BCRP) are among the most important drug transporters that determine the pharmacokinetics of many drugs and whose overexpression is associated with cancer chemoresistance. ABCC2 and ABCG2 expression is frequently altered during treatment, thus influencing efficacy and toxicity. Currently, there are no routine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38612955/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Is Diet a Determining Factor in the Induction of Gingival Inflammation by Dental Plaque? A Secondary Analysis of Clinical Studies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38612955-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The aim was to determine the association between plaque and gingival inflammation reported by dietary interventions. Data of four clinical studies dealing with changed nutrition and gingival examination were reanalyzed with regard to gingival inflammation (GI), plaque (PI), and bleeding on probing (BOP). Dietary changes basically involved avoiding sugar, white flour and sweetened drinks and focusing on whole foods for 4 weeks. The control groups were to maintain their usual diet. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613168/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240413180655&amp;v=2.18.0.post9&#43;e462414">Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613168-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240413180655-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Casitas B-lineage lymphoma (CBL) encodes an adaptor protein with E3-ligase activity negatively controlling intracellular signaling downstream of receptor tyrosine kinases. Somatic CBL mutations play a driver role in a variety of cancers, particularly myeloid malignancies, whereas germline defects in the same gene underlie a RASopathy having clinical overlap with Noonan syndrome (NS) and predisposing to juvenile myelomonocytic leukemia and vasculitis. Other features of the disorder &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613275/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Measurements of All-Particle Energy Spectrum and Mean Logarithmic Mass of Cosmic Rays from 0.3 to 30Â PeV with LHAASO-KM2A</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613275-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We present the measurements of all-particle energy spectrum and mean logarithmic mass of cosmic rays in the energy range of 0.3-30 PeV using data collected from LHAASO-KM2A between September 2021 and December 2022, which is based on a nearly composition-independent energy reconstruction method, achieving unprecedented accuracy. Our analysis reveals the position of the knee at 3.67Â±0.05Â±0.15 PeV. Below the knee, the spectral index is found to be -2.7413Â±0.0004Â±0.0050, while above the knee, it &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613276/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Amplitude Analysis of the B^{0}â†’K^{*0}Î¼^{&#43;}Î¼^{-} Decay</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613276-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    An amplitude analysis of the B^{0}â†’K^{*0}Î¼^{+}Î¼^{-} decay is presented using a dataset corresponding to an integrated luminosity of 4.7 fb^{-1} of pp collision data collected with the LHCb experiment. For the first time, the coefficients associated to short-distance physics effects, sensitive to processes beyond the standard model, are extracted directly from the data through a q^{2}-unbinned amplitude analysis, where q^{2} is the Î¼^{+}Î¼^{-} invariant mass squared. Long-distance &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613283/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Study of High-Transverse-Momentum Higgs Boson Production in Association with a Vector Boson in the qqbb Final State with the ATLAS Detector</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613283-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This Letter presents the first study of Higgs boson production in association with a vector boson (V=W or Z) in the fully hadronic qqbb final state using data recorded by the ATLAS detector at the LHC in proton-proton collisions at sqrt[s]=13 TeV and corresponding to an integrated luminosity of 137 fb^{-1}. The vector bosons and Higgs bosons are each reconstructed as large-radius jets and tagged using jet substructure techniques. Dedicated tagging algorithms exploiting b-tagging properties &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613325/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">The simulation experiment description markup language (SED-ML): language specification for level 1 version 5</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613325-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Modern biological research is increasingly informed by computational simulation experiments, which necessitate the development of methods for annotating, archiving, sharing, and reproducing the conducted experiments. These simulations increasingly require extensive collaboration among modelers, experimentalists, and engineers. The Minimum Information About a Simulation Experiment (MIASE) guidelines outline the information needed to share simulation experiments. SED-ML is a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38613393/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240413180704&amp;v=2.18.0.post9&#43;e462414">Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38613393-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240413180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Interactive Tree Of Life (<a href="https://itol.embl.de">https://itol.embl.de</a>) is an online tool for the management, display, annotation and manipulation of phylogenetic and other trees. It is freely available and open to everyone. iTOL version 6 introduces a modernized and completely rewritten user interface, together with numerous new features. A new dataset type has been introduced (colored/labeled ranges), greatly upgrading the functionality of the previous simple colored range annotation function. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9vxZEM3O">ä¸‹ç­è·¯ä¸Šï¼Œæ¯”èµ·Bay Bridgeï¼ŒSan Mateo Bridgeä¸Šçœ‹SF Bayï¼Œè®©äººè§‰å¾—æ›´wildã€‚ ç¾å›½Â·Coyote Hills Regional Park å­é™µåœ¨å¬æ­Œçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9vxzem3o/">
    
    
    
    
    
      
    
    ä¸‹ç­è·¯ä¸Šï¼Œæ¯”èµ·Bay Bridgeï¼ŒSan Mateo Bridgeä¸Šçœ‹SF Bayï¼Œè®©äººè§‰å¾—æ›´wildã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å›½Â·Coyote Hills Regional Park<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_vide">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_vide</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9w6Dyvs6">ç¾å›½æœ€å¤§çš„ä¸´åºŠåŒ»å­¦ç½‘ç«™MedScapeæ€»ç»“çš„2023å¹´ç¾å›½å„ä¸´åºŠä¸“ç§‘åŒ»ç”Ÿä¸­ä½æ”¶å…¥ï¼Œé—æ†¾çš„æ˜¯æ²¡å¿ƒå¤–ç§‘å’Œç¥ç»å¤–ç§‘ã€‚å…¶å®å…¨ä¸–ç•Œéƒ½å·®ä¸å¤šï¼Œéª¨ç§‘ï¼ˆå°¤å…¶æ˜¯è„ŠæŸ±å¤–ç§‘ï¼‰æœ€é«˜ï¼Œå…¶æ¬¡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9w6dyvs6/">
    
    
    
    
    
      
    
    ç¾å›½æœ€å¤§çš„ä¸´åºŠåŒ»å­¦ç½‘ç«™MedScapeæ€»ç»“çš„2023å¹´ç¾å›½å„ä¸´åºŠä¸“ç§‘åŒ»ç”Ÿä¸­ä½æ”¶å…¥ï¼Œé—æ†¾çš„æ˜¯æ²¡å¿ƒå¤–ç§‘å’Œç¥ç»å¤–ç§‘ã€‚å…¶å®å…¨ä¸–ç•Œéƒ½å·®ä¸å¤šï¼Œéª¨ç§‘ï¼ˆå°¤å…¶æ˜¯è„ŠæŸ±å¤–ç§‘ï¼‰æœ€é«˜ï¼Œå…¶æ¬¡æ˜¯å¿ƒå¤–ã€æ•´å½¢å’Œç¥å¤–ã€‚ä½†è¿™äº›ä¸´åºŠç§‘å®¤åœ¨ç¾å›½éœ€è¦åŒ»å­¦åšå£«MDæ¯•ä¸šåè¦åš5-7å¹´ä½é™¢åŒ»æ‰èƒ½æˆä¸ºä¸»æ²»åŒ»ã€‚å¦å¤–è¿˜è¦è€ƒè™‘é«˜æ˜‚çš„åŒ»å­¦é™¢å­¦è´¹å’Œè´·æ¬¾ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O9vDE9k5q">çœ‹åˆ°ä¸€æœ¬æ–°ä¹¦ä¹¦è®¯ï¼Œè¿˜æ²¡çœ‹ï¼Œä½†ä¸»é¢˜ç€å®æœ‰è¶£ã€‚ç ”ç©¶çš„æ˜¯é©å‘½æ–‡çŒ®ä¼ªè£…æœ¬ã€‚ç®€å•æ¥è¯´ï¼Œå°±æ˜¯åœ¨é©å‘½æ—¶æœŸï¼Œä¸ºäº†é¿å…æš´éœ²ï¼Œå¾ˆå¤šé©å‘½ä¹¦ç±ä¼šåœ¨å¤–é¢å¥—ä¸€å±‚é—²ä¹¦çš„çš®ï¼Œå°±å¥½åƒæˆ‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o9vde9k5q/">
    
    
    
    
    
      
    
    çœ‹åˆ°ä¸€æœ¬æ–°ä¹¦ä¹¦è®¯ï¼Œè¿˜æ²¡çœ‹ï¼Œä½†ä¸»é¢˜ç€å®æœ‰è¶£ã€‚ç ”ç©¶çš„æ˜¯é©å‘½æ–‡çŒ®ä¼ªè£…æœ¬ã€‚ç®€å•æ¥è¯´ï¼Œå°±æ˜¯åœ¨é©å‘½æ—¶æœŸï¼Œä¸ºäº†é¿å…æš´éœ²ï¼Œå¾ˆå¤šé©å‘½ä¹¦ç±ä¼šåœ¨å¤–é¢å¥—ä¸€å±‚é—²ä¹¦çš„çš®ï¼Œå°±å¥½åƒæˆ‘ä¸­å­¦ä¸Šæ•°å­¦è¯¾ï¼ŒæŠŠå€šå¤©å± é¾™è®°å¥—è¿›æ•°å­¦è¯¾æœ¬çš®ä¸€æ ·ã€‚è¿™ä»½ç›®å½•ç»†ç©¶èµ·æ¥å¯å¤ªå¥½ç©ï¼Œæ¯”å¦‚å¥—çš®ã€Šè’‹å§”å‘˜é•¿æ—¥è®°ã€‹ï¼Œè°è¯´å†™æ—¥è®°æ²¡ç”¨çš„â€¦â€¦ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O9w9MkAEI">æ˜¯çš„ï¼Œåœ°ç†çš„è®¤çŸ¥ä¼šå¸¦æ¥äº¤é€šçš„å˜åŒ–ï¼Œäº¤é€šçš„å˜åŒ–åˆä¼šæ”¹å˜å½“åœ°ç”Ÿæ´»ã€‚ - è½¬å‘ @é»”çµé•‡æ‹‰å¸ˆå‚…:&amp;ensp;â€œå¤œéƒäººâ€è§†è§’çœ‹é©¬ä¼¯åº¸æ–°è‘—ã€Šé£Ÿå—ä¹‹å¾’ã€‹ä¸­æåˆ°çš„å¤œéƒè‡³ç•ªç¦ºä¹‹è·¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o9w9mkaei/">
    
    
    
    
    
      
    
    æ˜¯çš„ï¼Œåœ°ç†çš„è®¤çŸ¥ä¼šå¸¦æ¥äº¤é€šçš„å˜åŒ–ï¼Œäº¤é€šçš„å˜åŒ–åˆä¼šæ”¹å˜å½“åœ°ç”Ÿæ´»ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é»”çµé•‡æ‹‰å¸ˆå‚…<!-- raw HTML omitted -->:â€‚â€œå¤œéƒäººâ€è§†è§’çœ‹é©¬ä¼¯åº¸æ–°è‘—ã€Šé£Ÿå—ä¹‹å¾’ã€‹ä¸­æåˆ°çš„å¤œéƒè‡³ç•ªç¦ºä¹‹è·¯ã€‚<!-- raw HTML omitted -->@é©¬ä¼¯åº¸<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->#é£Ÿå—ä¹‹å¾’#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%A9%AC%E4%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%A9%AC%E4%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9A1X6L4D">æ˜¯çœŸçš„ã€‚æ„å¤§åˆ©åŒ—éƒ¨é˜¿å°”å‘æ–¯å±±åŒºçš„å¤§ç†çŸ³é‡‡æ˜åœºï¼Œç½—é©¬æ—¶ä»£å°±å¼€å§‹å¼€é‡‡ï¼Œåˆ°ç°åœ¨æ²¡æŒ–å®Œã€‚ æŸ¥çœ‹å›¾ç‰‡ //@å°ä¸€å­322:è¿™çœŸæ˜¯çœŸçš„å•Š[å•èº«ç‹—] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;en...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9a1x6l4d/">
    
    
    
    
    
      
    
    æ˜¯çœŸçš„ã€‚æ„å¤§åˆ©åŒ—éƒ¨é˜¿å°”å‘æ–¯å±±åŒºçš„å¤§ç†çŸ³é‡‡æ˜åœºï¼Œç½—é©¬æ—¶ä»£å°±å¼€å§‹å¼€é‡‡ï¼Œåˆ°ç°åœ¨æ²¡æŒ–å®Œã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¥çœ‹å›¾ç‰‡<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@å°ä¸€å­322<!-- raw HTML omitted -->:è¿™çœŸæ˜¯çœŸçš„å•Š<!-- raw HTML omitted -->&lt;img alt=&quot;[å•èº«ç‹—]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/_/co_niuec-7d0">https://h5.sinaimg.cn/m/emoticon/icon/_/co_niuec-7d0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9A5p9ySX">ğŸ”»æ‚‰å°¼ç¬¬ä¸ƒæ–°é—»é¢‘é“ï¼ˆè§†é¢‘1ï¼‰å’Œä¿„æ–°ç¤¾ï¼ˆå›¾2ï¼‰éƒ½è¡¨ç¤ºï¼šåœ¨æ¾³å¤§åˆ©äºšæ‚‰å°¼è´­ç‰©ä¸­å¿ƒè¢­å‡»äº‹ä»¶ä¸­æŒºèº«è€Œå‡ºæ‹¦ä½è¢­å‡»è€…çš„è§ä¹‰å‹‡ä¸ºç”·å­ï¼ˆè§†é¢‘3ï¼‰ï¼Œæ˜¯ä¸€åä¿„å›½äººã€‚ğŸ”»ä¿„æ–°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9a5p9ysx/">
    
    
    
    
    
      
    
    ğŸ”»æ‚‰å°¼ç¬¬ä¸ƒæ–°é—»é¢‘é“ï¼ˆè§†é¢‘1ï¼‰å’Œä¿„æ–°ç¤¾ï¼ˆå›¾2ï¼‰éƒ½è¡¨ç¤ºï¼šåœ¨æ¾³å¤§åˆ©äºšæ‚‰å°¼è´­ç‰©ä¸­å¿ƒè¢­å‡»äº‹ä»¶ä¸­æŒºèº«è€Œå‡ºæ‹¦ä½è¢­å‡»è€…çš„è§ä¹‰å‹‡ä¸ºç”·å­ï¼ˆè§†é¢‘3ï¼‰ï¼Œæ˜¯ä¸€åä¿„å›½äººã€‚<!-- raw HTML omitted -->ğŸ”»ä¿„æ–°ç¤¾è¯´ï¼šä»–ç”¨ä¿„è¯­å–Šâ€œĞĞµ Ğ¿Ğ¾Ğ´Ñ…Ğ¾Ğ´Ğ¸!ï¼ˆåˆ«è¿‡æ¥ï¼ï¼‰â€ï¼Œå¹¶æŒ¥èˆä¸€æ ¹éš”ç¦»æ†é˜»æ­¢è¢­å‡»è€…å‰è¿›ã€‚<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»æºï¼šä¿„æ–°ç¤¾ VK å®˜æ–¹è´¦æˆ· / æ‚‰å°¼ 7 NEWS<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9AcoDEil">ğŸ”»å•Šï¼Ÿ[å“†å•¦Aæ¢¦å®³æ€•]ğŸ”»[èœ¡çƒ›]#ç§¦çš‡å²›ä¸€èˆ¹åªä¾§ç¿»å·²è‡´12æ­»6å¤±è”#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9acodeil/">
    
    
    
    
    
      
    
    ğŸ”»å•Šï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%A7%A6%E7%9A%87%E5%B2%9B%E4%B8%80%E8%88%B9%E5%8F%AA%E4%BE%A7%E7%BF%BB%E5%B7%B2%E8%87%B412%E6%AD%BB6%E5%A4%B1%E8%81%94%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%A7%A6%E7%9A%87%E5%B2%9B%E4%B8%80%E8%88%B9%E5%8F%AA%E4%BE%A7%E7%BF%BB%E5%B7%B2%E8%87%B412%E6%AD%BB6%E5%A4%B1%E8%81%94%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9AhfxTjJ">ğŸ”»ä»Šå¤©åœ¨æ‚‰å°¼ç¬¬ä¸€æ—¶é—´å†²å‘ç°åœºçš„æ¾³å¤§åˆ©äºšå¥³è­¦å¯Ÿ Amy Scott å’Œè·Ÿéšå¥¹æç€æ¤…å­å¥”è·‘çš„ç”·å£«ä»¬ä¹Ÿéå¸¸è‹±å‹‡ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9ahfxtjj/">
    
    
    
    
    
      
    
    ğŸ”»ä»Šå¤©åœ¨æ‚‰å°¼ç¬¬ä¸€æ—¶é—´å†²å‘ç°åœºçš„æ¾³å¤§åˆ©äºšå¥³è­¦å¯Ÿ Amy Scott å’Œè·Ÿéšå¥¹æç€æ¤…å­å¥”è·‘çš„ç”·å£«ä»¬ä¹Ÿéå¸¸è‹±å‹‡ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/LEZi92B1lx08e3ItQDoA010412001K1x0E010.mp4?label=mp4_720p&amp;amp;template=720x908.24.0&amp;amp;ori=0&amp;amp;ps=1CwnkDw1GXwCQx&amp;amp;Expires=1713043853&amp;amp;ssig=xZfcq2%2Bt1W&amp;amp;KID=unisto">https://f.video.weibocdn.com/o0/LEZi92B1lx08e3ItQDoA010412001K1x0E010.mp4?label=mp4_720p&amp;amp;template=720x908.24.0&amp;amp;ori=0&amp;amp;ps=1CwnkDw1GXwCQx&amp;amp;Expires=1713043853&amp;amp;ssig=xZfcq2%2Bt1W&amp;amp;KID=unisto</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9AmQ5iCt">ğŸ”»å½“åœ°æ—¶é—´4æœˆ11æ—¥ä¸­åˆ12:30ï¼Œ8 åæŒ æª å«Œ çŠ¯æ´—åŠ«äº†ç¾å›½å¥¥å…‹å…°å”äººè¡—çš„è€å­—å·ç å®åº— Phuong Jewelryã€‚ğŸ”»åº—ä¸» Diane çš„å„¿å­ Tony Trinh è¯´ï¼šâ€œæˆ‘ä»¬ä»¥å‰è¢«æŠ¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9amq5ict/">
    
    
    
    
    
      
    
    ğŸ”»å½“åœ°æ—¶é—´4æœˆ11æ—¥ä¸­åˆ12:30ï¼Œ8 åæŒ æª å«Œ çŠ¯æ´—åŠ«äº†ç¾å›½å¥¥å…‹å…°å”äººè¡—çš„è€å­—å·ç å®åº— Phuong Jewelryã€‚<!-- raw HTML omitted -->ğŸ”»åº—ä¸» Diane çš„å„¿å­ Tony Trinh è¯´ï¼šâ€œæˆ‘ä»¬ä»¥å‰è¢«æŠ¢è¿‡å‡ æ¬¡ï¼Œä½†æ²¡æœ‰è¿™ä¹ˆæ˜ç›®å¼ èƒ†ã€‚å…«ä¸ªäººï¼Œä¸¤è¾†é€ƒè·‘çš„æ±½è½¦ï¼Œè¿˜æ‹”å‡ºäº†æªï¼Œåœ¨å¬åˆ°æ¶ˆæ¯åï¼Œæˆ‘æƒ³ï¼Œæˆ‘æ¯äº²ä¸­æªäº†å—ï¼Ÿæˆ‘çˆ¶äº²ä¸­æªäº†å—ï¼Ÿæˆ‘ä»¬çš„å‘˜å·¥ä¸­æœ‰äººä¸­æªå—ï¼Ÿâ€<!-- raw HTML omitted -->ğŸ”»Tony Trinh å£°ç§°åº—å†…æŸå¤±äº† 85-90% çš„å­˜è´§ï¼Œç”±äºå½“æ—¶æ²¡æœ‰ä¿å®‰å€¼ç­ï¼Œ76å²çš„ç”·åº—ä¸»ä¸å¾—ä¸è‡ªå·±æ‹¿æªèµ¶è·‘äº†å«Œ çŠ¯ã€‚<!-- raw HTML omitted -->ğŸ”»ç™½ æ—¥ æŠ¢ åŠ«ã€‚<!-- raw HTML omitted -->ğŸ”»æ–°é—»çš„ç»“å±€æ˜¯ï¼šç”±äºä¿è´¹ä¸æ–­ä¸Šæ¶¨ï¼Œä»–ä»¬å®¶çš„å•†ä¸šä¿é™©å¤±æ•ˆäº†ï¼Œâ€œDiane çš„ç¾å›½æ¢¦åœ¨ä¸åˆ°ä¸€åˆ†é’Ÿå†…å°±ç ´ç­äº†ï¼ˆDiane&rsquo;s American Dream, gone in less than a minuteï¼‰â€<!-- raw HTML omitted -->ğŸ”»æºï¼šabc7news<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9AoyAy8o">ğŸ”»åœ£å½¼å¾—å ¡ä¸€åˆ—æœ‰è½¨ç”µè½¦å†² æ’äº†æ–‘é©¬çº¿ä¸Šçš„äººç¾¤â€¦â€¦è‡³å°‘3äººå— ä¼¤ã€‚ğŸ”»ä¿„ç½—æ–¯è­¦æ–¹çš„åˆæ­¥ç»“è®ºæ˜¯åˆ¹è½¦å¤±çµã€‚ğŸ”»æˆ‘è¿˜çœŸçš„å¾ˆå°‘çœ‹åˆ°æœ‰è½¨ç”µè½¦çš„è½¦ ç¥¸[å“†å•¦Aæ¢¦åƒæƒŠ]ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9aoyay8o/">
    
    
    
    
    
      
    
    ğŸ”»åœ£å½¼å¾—å ¡ä¸€åˆ—æœ‰è½¨ç”µè½¦å†² æ’äº†æ–‘é©¬çº¿ä¸Šçš„äººç¾¤â€¦â€¦è‡³å°‘3äººå— ä¼¤ã€‚<!-- raw HTML omitted -->ğŸ”»ä¿„ç½—æ–¯è­¦æ–¹çš„åˆæ­¥ç»“è®ºæ˜¯åˆ¹è½¦å¤±çµã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘è¿˜çœŸçš„å¾ˆå°‘çœ‹åˆ°æœ‰è½¨ç”µè½¦çš„è½¦ ç¥¸<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼ŒæŒ‰ç†è¯´è¿™ç§è½¦é€Ÿåº¦å¹¶ä¸å¿«ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šRTçš„VKé¢‘é“ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hopnamnxuej20z">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hopnamnxuej20z</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9ApgkEHa">ğŸ”»ä¸è¦ç†¬å¤œï¼Œç†¬å¤œå¯¹æ‰‹æœºä¸å¥½ã€‚ğŸ”»æ„¿å¤§å®¶çš„çƒ¦æ¼åƒæ§èŠ±ä¸€æ ·è¢«æŠ›å¼ƒï¼Œæ™šå®‰ã€‚ğŸ”»ä»Šæ™šä¼Šæœ—ä¸æä»¥è‰²åˆ—å§ï¼Ÿä¸ä¼šåŠ¨å§ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9apgkeha/">
    
    
    
    
    
      
    
    ğŸ”»ä¸è¦ç†¬å¤œï¼Œç†¬å¤œå¯¹æ‰‹æœºä¸å¥½ã€‚<!-- raw HTML omitted -->ğŸ”»æ„¿å¤§å®¶çš„çƒ¦æ¼åƒæ§èŠ±ä¸€æ ·è¢«æŠ›å¼ƒï¼Œæ™šå®‰ã€‚<!-- raw HTML omitted -->ğŸ”»ä»Šæ™šä¼Šæœ—ä¸æä»¥è‰²åˆ—å§ï¼Ÿä¸ä¼šåŠ¨å§ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/lUC5gp4Clx08e3JQ7j56010412005hKx0E010.mp4?label=mp4_hd">https://f.video.weibocdn.com/o0/lUC5gp4Clx08e3JQ7j56010412005hKx0E010.mp4?label=mp4_hd</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9zTdivMp">æŒ‰æ¯”ä¾‹æ¥è¯´ï¼Œç°åœ¨å›½å†…åƒè¾£çš„åœ°åŒºï¼Œæ¯”ä¾‹æ¯”æ˜¥ç§‹æˆ˜å›½é‚£ä¼šå„¿ä½å¤šäº†ã€‚ä¸æ‡‚ä½ æƒ³è¡¨è¾¾ä»€ä¹ˆã€‚//@Ematrapsa:æ‰€ä»¥ä¸ºå•¥ç°åœ¨åƒè¾£æ˜¯ä»¥è¾£æ¤’ä¸ºä¸»å‘¢ï¼Œå›½å†…æ¯”èµ›åƒè¾£ä¹Ÿæ²¡æœ‰æ¯”åƒèŠ±æ¤’...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9ztdivmp/">
    
    
    
    
    
      
    
    æŒ‰æ¯”ä¾‹æ¥è¯´ï¼Œç°åœ¨å›½å†…åƒè¾£çš„åœ°åŒºï¼Œæ¯”ä¾‹æ¯”æ˜¥ç§‹æˆ˜å›½é‚£ä¼šå„¿ä½å¤šäº†ã€‚ä¸æ‡‚ä½ æƒ³è¡¨è¾¾ä»€ä¹ˆã€‚//<!-- raw HTML omitted -->@Ematrapsa<!-- raw HTML omitted -->:æ‰€ä»¥ä¸ºå•¥ç°åœ¨åƒè¾£æ˜¯ä»¥è¾£æ¤’ä¸ºä¸»å‘¢ï¼Œå›½å†…æ¯”èµ›åƒè¾£ä¹Ÿæ²¡æœ‰æ¯”åƒèŠ±æ¤’çš„å§<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ç™½â€¦â€¦è›‹é¥­ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸œå—äºšçš„ï¼Œæ˜¯ä¸æ˜¯ç¬é—´é¡ºçœ¼å¾ˆå¤šã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šmsangelworld/vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9zUJrv1q">ğŸ”»ä¸€å50å²çš„ç¾å›½é©»ä»¥è‰²åˆ—å¤§ä½¿é¦†å‰é›‡å‘˜å’Œç¾å›½å›½é™…å¼€å‘ç½²USAIDç°é›‡å‘˜ã€ä»¥è‰²åˆ—å…¬æ°‘é›…ç§‘å¤«Â·æ‰˜å¸Œï¼Œå› ä¸ºåœ¨é›…æ³•è¡—å¤´æ•‘ æ²»ä¸€åè½¦ ç¥¸ ä¼¤ å‘˜æ—¶ä¸ä¸€åä»¥è‰²åˆ—ä¾¿æœä¼‘ç­è­¦...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9zujrv1q/">
    
    
    
    
    
      
    
    ğŸ”»ä¸€å50å²çš„ç¾å›½é©»ä»¥è‰²åˆ—å¤§ä½¿é¦†å‰é›‡å‘˜å’Œç¾å›½å›½é™…å¼€å‘ç½²USAIDç°é›‡å‘˜ã€ä»¥è‰²åˆ—å…¬æ°‘é›…ç§‘å¤«Â·æ‰˜å¸Œï¼Œå› ä¸ºåœ¨é›…æ³•è¡—å¤´æ•‘ æ²»ä¸€åè½¦ ç¥¸ ä¼¤ å‘˜æ—¶ä¸ä¸€åä»¥è‰²åˆ—ä¾¿æœä¼‘ç­è­¦å¯Ÿå‘ç”Ÿå£è§’å’Œäº‰æ‰§ï¼Œè¢«è¿™åè­¦å¯Ÿè¿å¼€æ•°æªæ‰“ æ­»ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™åé›…æ³•å±…æ°‘å› ä¸ºç»™ç¾å›½äººçš„æœºæ„å¤šå¹´æœåŠ¡ï¼Œåœ¨å½“åœ°è¿˜é¢‡æœ‰åæ°”ï¼Œæœ¬èº«ä¹Ÿæ˜¯ä»¥è‰²åˆ— æ•‘ æ´ è” ç›ŸMDAçš„å¿—æ„¿è€…ã€‚<!-- raw HTML omitted -->ğŸ”»ä»–æœ¬äººæ˜¯å·´å‹’æ–¯å¦è£”ï¼Œä¸æ¸…æ¥šè¿™ä¸ä»¥è‰²åˆ—è­¦å¯Ÿé€‰æ‹©åœ¨åµæ¶åç«‹å³ å°„ æ€ ä»– æœ‰æ²¡æœ‰å…³ç³»ï¼Œç›®å‰è¿™åä»¥è‰²åˆ—ä¼‘ç­è­¦å¯Ÿå·²ç»è¢« é€® æ•ã€‚<!-- raw HTML omitted -->ğŸ”»çœ‹çœ‹ä»¥è‰²åˆ—å®‰ å…¨éƒ¨é•¿æœ¬æ ¼ç»´ä¼šä¸ä¼šå…´é«˜é‡‡çƒˆçš„ä¸ºè¿™åè­¦å¯Ÿç‚¹èµå°±çŸ¥é“äº†ã€‚<!-- raw HTML omitted -->ğŸ”»ä¹Ÿè®¸æ²¡æœ‰å§ã€‚<!-- raw HTML omitted -->ğŸ”»æ–°é—»æºï¼šä»¥è‰²åˆ—æ–°æ¶ˆæ¯æŠ¥ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9zXGDHRf">ğŸ”»å¤§ç†çŸ³é‡‡çŸ³åœºçš„è§„æ¨¡å¯ä»¥å¤§åˆ°è®©æŒ–æ˜æœºçœ‹èµ·æ¥å°±åƒä¸€ä¸ªç©å…·ã€‚ğŸ”»æˆ‘ä»¬ç¼ºä¹è¿™æ ·å“è´¨çš„å»ºç­‘ææ–™ï¼Œæ‰€ä»¥è€ç¥–å®—åœ¨æœ¨æ„ä¸Šç©å‡ºäº†èŠ±ã€‚ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9zxgdhrf/">
    
    
    
    
    
      
    
    ğŸ”»å¤§ç†çŸ³é‡‡çŸ³åœºçš„è§„æ¨¡å¯ä»¥å¤§åˆ°è®©æŒ–æ˜æœºçœ‹èµ·æ¥å°±åƒä¸€ä¸ªç©å…·ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘ä»¬ç¼ºä¹è¿™æ ·å“è´¨çš„å»ºç­‘ææ–™ï¼Œæ‰€ä»¥è€ç¥–å®—åœ¨æœ¨æ„ä¸Šç©å‡ºäº†èŠ±ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9vNkBIPk">å”‰ çœŸå–œæ¬¢çºªå·ä¹…ğŸš¬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9vnkbipk/">
    
    
    
    
    
      
    
    å”‰ çœŸå–œæ¬¢çºªå·ä¹…ğŸš¬  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9vW6ytQE">ä»¬ç»‡å„¿æœ€è¿‘çš„å·¥ä½œä¸ä¼šå°±æ˜¯æ’ç»ƒå§ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9vw6ytqe/">
    
    
    
    
    
      
    
    ä»¬ç»‡å„¿æœ€è¿‘çš„å·¥ä½œä¸ä¼šå°±æ˜¯æ’ç»ƒå§ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9w9ybRmr">å¯çˆ±æ™•äº† - è½¬å‘ @é’¢æ³¢Orz:&amp;ensp;å¤§çœ¼ğŸ‘€ç¾é£Ÿå®¶TAMAé…±2.0 é’¢æ³¢Orzçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9w9ybrmr/">
    
    
    
    
    
      
    
    å¯çˆ±æ™•äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é’¢æ³¢Orz<!-- raw HTML omitted -->:â€‚å¤§çœ¼ğŸ‘€ç¾é£Ÿå®¶TAMAé…±2.0 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->é’¢æ³¢Orzçš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaimg.cn/orj480/006feNaVgy1hop4hdygn0j30u00gwjua.jpg%22">https://tvax4.sinaimg.cn/orj480/006feNaVgy1hop4hdygn0j30u00gwjua.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9xomaSfU">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.bubka_henshuubu [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9xomasfu/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.bubka_henshuubu &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hopa0k1j4wj30us153tgf.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hopa0k1j4wj30us153tgf.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9yp3saC5">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆ2ndå†™çœŸé›†##å¥³ä¸»è§’# ä¸å±±ä¸‹æ¡‘ä¸€èµ·å¼€å§‹å€’è®¡æ—¶ğŸŒ™è·ç¦»å†™çœŸé›†å‘å”®è¿˜æœ‰ï½¥ï½¥ï½¥10å¤©ğŸ¬ğŸŒŸAmazon:ç½‘é¡µé“¾æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9yp3sac5/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9yVTqNnD">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ 240406 ã€ŒVenue101ã€ä¹ƒæœ¨å‚46éƒ¨åˆ†cutbç«™:ã€å±±ä¸‹ç¾æœˆã€‘240406 æœ€åä¸€æ¬¡éŸ³ä¹ç•ªç»„ã€ä¸­å­—ã€‘ å±±ä¸‹ç¾æœˆæ•™ä¼šçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9yvtqnnd/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->240406 ã€ŒVenue101ã€ä¹ƒæœ¨å‚46éƒ¨åˆ†cut<!-- raw HTML omitted -->bç«™:&lt;a href=&ldquo;<a href="https://www.bilibili.com/video/BV1MC411V7ff/?vd_source=2d56f651">https://www.bilibili.com/video/BV1MC411V7ff/?vd_source=2d56f651</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O9vnziImk">æ¯æ—¥ä¸€ä¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o9vnziimk/">
    
    
    
    
    
      
    
    æ¯æ—¥ä¸€ä¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O9zch4shb">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.bubka_henshuubu [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o9zch4shb/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.bubka_henshuubu &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hopa0k1j4wj30us153tgf.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hopa0k1j4wj30us153tgf.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O9ylWFKQV">ç°åœ¨å¾ˆå¤šäººéƒ½å–œæ¬¢æ ¹æ®è‡ªå·±çš„æ£æµ‹ï¼Œæ¥æ„æ·«å½“äº‹äººçš„æƒ³æ³•ï¼Œå¹¶ä¸”èŠ±å°½å¿ƒæ€å°†è‡ªå·±çš„æ£æµ‹å˜æˆä»–çš„è¨€è®ºçœŸçš„å¾ˆæ— èŠ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o9ylwfkqv/">
    
    
    
    
    
      
    
    ç°åœ¨å¾ˆå¤šäººéƒ½å–œæ¬¢æ ¹æ®è‡ªå·±çš„æ£æµ‹ï¼Œæ¥æ„æ·«å½“äº‹äººçš„æƒ³æ³•ï¼Œå¹¶ä¸”èŠ±å°½å¿ƒæ€å°†è‡ªå·±çš„æ£æµ‹å˜æˆä»–çš„è¨€è®º<!-- raw HTML omitted --><!-- raw HTML omitted -->çœŸçš„å¾ˆæ— èŠ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9xnYdF2x">ä¹…ä¿å²ç»ªé‡Œvia.bubka_henshuubu [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9xnydf2x/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.bubka_henshuubu <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1gF4m1K7Wy">é™ˆç¿”å…­ç‚¹åŠï¼šèŒåœºæ— é—´é£äº‘èµ·ï¼Œåé—´è®¡é‡Œå®šä¹¾å¤</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1gf4m1k7wy/">
    
    
    
    
    
      
    
    è¿™åœºèŒåœºâ€œæš—æˆ˜â€ä½ ç«™å“ªè¾¹ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/pin/1762482359897870337">é‡å­ä½å‘å¸ƒäº†æƒ³æ³•: ç¾å›¾å…¬å¸åˆ›å§‹äººã€è‘£äº‹é•¿å…¼é¦–å¸­æ‰§è¡Œå®˜å´æ¬£é¸¿ ç¡®è®¤å‚ä¸ #ä¸­å›½AIGCäº§ä¸šå³°ä¼š ï¼ğŸ”¥&lt;br&gt;&lt;br&gt;2008å¹´ï¼Œå´æ¬£é¸¿åˆ›ç«‹ç¾å›¾å…¬å¸ã€‚æ——ä¸‹äº§å“ç¾å›¾ç§€ç§€ã€ç¾é¢œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-pin-1762482359897870337/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/pin/1762483559426818050">é‡å­ä½å‘å¸ƒäº†æƒ³æ³•: å•†æ±¤ç§‘æŠ€è”åˆåˆ›å§‹äººï¼Œå¤§è£…ç½®äº‹ä¸šç¾¤æ€»è£æ¨å¸† ç¡®è®¤å‚ä¸ #ä¸­å›½AIGCäº§ä¸šå³°ä¼š ï¼ğŸ”¥&lt;br&gt;&lt;br&gt;æ¨å¸†è´Ÿè´£å•†æ±¤æˆ˜ç•¥ä¸šåŠ¡å¤§è£…ç½®è½åœ°ï¼Œä¸»å¯¼å»ºæˆâ€œå•†æ±¤ç§‘æŠ€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-pin-1762483559426818050/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/pin/1762617646401761280">é‡å­ä½å‘å¸ƒäº†æƒ³æ³•: æ˜†ä»‘ä¸‡ç»´è‘£äº‹é•¿å…¼CEOæ–¹æ±‰ ç¡®è®¤å‚ä¸ #ä¸­å›½AIGCäº§ä¸šå³°ä¼š ï¼ğŸ”¥&lt;br&gt;&lt;br&gt;æ–¹æ±‰ï¼Œæ˜†ä»‘ä¸‡ç»´è‘£äº‹é•¿å…¼CEOã€‚æ¯•ä¸šäºä¸­å›½ç§‘å­¦æŠ€æœ¯å¤§å­¦è¿‘ä»£ç‰©ç†ç³»ï¼Œæ›¾ä»»èŒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-pin-1762617646401761280/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/35399483/answer/3464929383">çŒ«å“¥çš„è§†ç•Œå›ç­”äº†é—®é¢˜: ä¸œå—äºšå„å›½å¯¹ä¸­å›½äººçš„æ€åº¦éƒ½å¦‚ä½•ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-35399483-answer-3464929383/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692273159">é‡å­ä½å‘è¡¨äº†æ–‡ç« : NeurIPSå¼€è¾Ÿé«˜ä¸­èµ›é“å¼•çˆ†äº‰è®®ï¼ç½‘å‹ï¼šä»£ç†äººæˆ˜äº‰è¦å¼€å§‹äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692273159/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692273877">é‡å­ä½å‘è¡¨äº†æ–‡ç« : â€œéŸ³ä¹ç‰ˆSoraâ€æœåŠ¡å™¨æŒ¤çˆ†ï¼åŠŸèƒ½æ¯”Sunoä¸°å¯Œè¿˜èƒ½ç”Ÿæˆè„±å£ç§€</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-13</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692273877/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38605638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240412180604&amp;v=2.18.0.post9&#43;e462414">SEGCECO: Subgraph Embedding of Gene expression matrix for prediction of CEll-cell COmmunication</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38605638-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240412180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent advances in single-cell RNA sequencing technology have eased analyses of signaling networks of cells. Recently, cell-cell interaction has been studied based on various link prediction approaches on graph-structured data. These approaches have assumptions about the likelihood of node interaction, thus showing high performance for only some specific networks. Subgraph-based methods have solved this problem and outperformed other approaches by extracting local subgraphs from a given &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38605638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240413180646&amp;v=2.18.0.post9&#43;e462414">SEGCECO: Subgraph Embedding of Gene expression matrix for prediction of CEll-cell COmmunication</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38605638-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240413180646-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent advances in single-cell RNA sequencing technology have eased analyses of signaling networks of cells. Recently, cell-cell interaction has been studied based on various link prediction approaches on graph-structured data. These approaches have assumptions about the likelihood of node interaction, thus showing high performance for only some specific networks. Subgraph-based methods have solved this problem and outperformed other approaches by extracting local subgraphs from a given &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38605980/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Aberrant brain dynamics in individuals with clinical high risk of psychosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38605980-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In CHR, temporal brain dynamics are attracted to an infrequent brain state, reflecting more frequent and longer occurrence of aberrant interactions of default mode, salience, and limbic networks. Concurrently, more frequent and longer occurrence of the brain state is associated with core cognitive dysfunctions, predictors of future onset of full-blown &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38605986/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Levofloxacin loaded poly (ethylene oxide)-chitosan/quercetin loaded poly (D,L-lactide-co-glycolide) core-shell electrospun nanofibers for burn wound healing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38605986-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study developed a new burn wound dressing based on core-shell nanofibers that co-deliver antibiotic and antioxidant drugs. For this purpose, poly(ethylene oxide) (PEO)-chitosan (CS)/poly(D,L-lactide-co-glycolide) (PLGA) core-shell nanofibers were fabricated through co-axial electrospinning technique. Antibiotic levofloxacin (LEV) and antioxidant quercetin (QS) were incorporated into the core and shell parts of PEO-CS/PLGA nanofibers, respectively. The drugs could bond to the polymer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606187/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Extending BioMASS to construct mathematical models from external knowledge</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606187-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: Mechanistic modeling based on ordinary differential equations has led to numerous findings in systems biology by integrating prior knowledge and experimental data. However, the manual curation of knowledge necessary when constructing models poses a bottleneck. As the speed of knowledge accumulation continues to grow, there is a demand for a scalable means of constructing executable &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606262/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Self-Shielding Gyroscopic Radiosurgery: A Prospective Experience and Analysis of the First 100 Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606262-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background Stereotactic radiosurgery is a well-established treatment option for the management of various benign and malignant brain tumors. It can be delivered with several treatment platforms, usually requiring shielded radiation vaults to meet regulatory safety requirements. Recent technical advances have led to the first self-shielding platform enabling the delivery of gyroscopic radiosurgery (GRS). Given the limited number of GRS treatment platforms, the novelty of its characteristics, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606472/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Academia or Industry: Lessons on Choosing Career Pathsâ”€There May Be More Than One Fork in the Road Ahead</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606472-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606558/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606558-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our data display heterogeneity within the group of vasoresponders, with a large subset failing to show a sustained satisfactory clinical response to CCBs. This highlights the necessity for comprehensive reassessment during early follow-up. The use of pulmonary artery compliance in addition to current measures may better identify those likely to have a good long-term &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to pancreatic ductal adenocarcinoma susceptibility. However, in the last decade, genetic association studies performed on several human traits have greatly increased the number of known pleiotropic variants. Based on the hypothesis that variants already associated with a least one &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606831/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">The digital revolution in pathology: Towards a smarter approach to research and treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606831-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Artificial intelligence (AI) applications in oncology are at the forefront of transforming healthcare during the Fourth Industrial Revolution, driven by the digital data explosion. This review provides an accessible introduction to the field of AI, presenting a concise yet structured overview of the foundations of AI, including expert systems, classical machine learning, and deep learning, along with their contextual application in clinical research and healthcare. We delve into the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38606899/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38606899-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Alcohol Use Disorder (AUD) poses an ongoing significant global health burden. AUD is highly prevalent and affects not only the individuals with AUD, but also their communities and society at large. Even though pharmacotherapy is an integral part of AUD treatment, the few available substances show limited efficacy and limited clinical impact. Thus, there is a need for new innovative pharmacotherapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607053/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607053-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The possibility of impacting triple-negative breast cancer cells with engineered Adipose-Derived Stem Cell Exosomes is real. The opportunity to translate our current in vitro analyses into a future in vivo scenario is even more &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607230/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Comment on: &#39;Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart&#39; by Saint-Martin Willer etÂ al</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607230-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240412180729&amp;v=2.18.0.post9&#43;e462414">Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607410-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240412180729-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The phase 3 INO-VATE trial demonstrated higher rates of remission, measurable residual disease negativity, and improved overall survival for patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) who received inotuzumab ozogamicin (InO) vs standard of care chemotherapy (SC). Here we examined associations between genomic alterations and the efficacy of InO. Of 326 randomized patients, 91 (InO, n=43; SC, n=48) had samples evaluable for genomic analysis. The spectrum of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240413180655&amp;v=2.18.0.post9&#43;e462414">Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607410-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240413180655-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The phase 3 INO-VATE trial demonstrated higher rates of remission, measurable residual disease negativity, and improved overall survival for patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) who received inotuzumab ozogamicin (InO) vs standard of care chemotherapy (SC). Here we examined associations between genomic alterations and the efficacy of InO. Of 326 randomized patients, 91 (InO, n=43; SC, n=48) had samples evaluable for genomic analysis. The spectrum of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607418/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Comparison of 3T and 7T magnetic resonance imaging for direct visualization of finger flexor pulley rupture: an ex-vivo study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607418-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MRI at 3T allows a comparable diagnostic performance to 7T for direct visualization and characterization of finger flexor pulleys before and after rupture, with superiority of 7T MRI in the visualization of the normal A3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38607534/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240412180741&amp;v=2.18.0.post9&#43;e462414">Cognitive assessment during the phases of a spontaneous migraine: a prospective cohort study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38607534-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240412180741-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The headache and postdromal phase of a migraine day was associated with objective evidence of cognitive dysfunction in patients with episodic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38608320/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240413180639&amp;v=2.18.0.post9&#43;e462414">Efficient leukocytes detection and classification in microscopic blood images using convolutional neural network coupled with a dual attention network</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38608320-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240413180639-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Leukocytes, also called White Blood Cells (WBCs) or leucocytes, are the cells that play a pivotal role in human health and are vital indicators of diseases such as malaria, leukemia, AIDS, and other viral infections. WBCs detection and classification in blood smears offers insights to pathologists, aiding diagnosis across medical conditions. Traditional techniques, including manual counting, detection, classification, and visual inspection of microscopic images by medical professionals, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38609316/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=12guA9dSu1tIGuMz6q_NmVi5YCwW3jEzF9ajGRxJKG5GGImktL&amp;fc=20220328030059&amp;ff=20240413180315&amp;v=2.18.0.post9&#43;e462414">Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38609316-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-12gua9dsu1tigumz6q-nmvi5ycww3jezf9ajgrxjkg5ggimktl-fc-20220328030059-ff-20240413180315-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This phase 1 clinical trial demonstrates that early introduction of immunotherapy after ASCT is well tolerated and shows promising disease control in patients with MM, accompanied by favorable changes in the immune &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38609386/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240413180655&amp;v=2.18.0.post9&#43;e462414">Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38609386-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240413180655-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9kWTkBxT">Nature Immunologyå‘è¡¨äº†ä¸€ç¯‡ååˆ†é‡è¦çš„æ–°å† åé—ç—‡ï¼ˆLong COVIDï¼‰ç ”ç©¶ï¼Œæ¥è‡ªå¸å›½ç†å·¥å­¦é™¢ã€‚Long COVIDç°åœ¨çš„ç ”ç©¶é›†ä¸­åœ¨æ…¢æ€§ç‚ç—‡å’Œå…ç–«åŠŸèƒ½å¤±è°ƒé¢†åŸŸã€‚è¿™é¡¹ç ”ç©¶åˆ†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9kwtkbxt/">
    
    
    
    
    
      
    
    Nature Immunologyå‘è¡¨äº†ä¸€ç¯‡ååˆ†é‡è¦çš„æ–°å† åé—ç—‡ï¼ˆLong COVIDï¼‰ç ”ç©¶ï¼Œæ¥è‡ªå¸å›½ç†å·¥å­¦é™¢ã€‚Long COVIDç°åœ¨çš„ç ”ç©¶é›†ä¸­åœ¨æ…¢æ€§ç‚ç—‡å’Œå…ç–«åŠŸèƒ½å¤±è°ƒé¢†åŸŸã€‚è¿™é¡¹ç ”ç©¶åˆ†æäº†657åå…·æœ‰æŒç»­3ä¸ªæœˆä»¥ä¸Šç—‡çŠ¶COVID-19æ‚£è€…(426äººå…·æœ‰Long COVIDè¡¨ç°)çš„368ç§è¡€æµ†è›‹ç™½ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç ”ç©¶å‘ç°ï¼Œè¿™äº›æ‚£è€…çš„é«“ç³»ç»†èƒæ¿€æ´»å’Œè¡¥ä½“å‡é«˜ä¸Long COVIDå…·æœ‰ç›¸å…³æ€§ã€‚å…¶ä¸­ï¼ŒIL-1R2ã€MATN2å’ŒCOLEC12ä¸å¿ƒè¡€ç®¡åŠå‘¼å¸ç—‡çŠ¶ã€ç–²åŠ³ã€ç„¦è™‘å’ŒæŠ‘éƒç›¸å…³ï¼› MATN2ã€CSF3å’ŒC1QAåœ¨å…·æœ‰èƒƒè‚ é“è¡¨ç°æ‚£è€…ä¸­å‡é«˜ï¼›C1QAåœ¨å…·æœ‰è®¤çŸ¥éšœç¢æ‚£è€…ä¸­å‡é«˜ã€‚å¦å¤–ï¼Œç¥ç»æŸä¼¤ä¿®å¤çš„æ ‡è®°ç‰©SPON-1å’ŒNFASCä»¥åŠè„‘è‚ è½´æ ‡è®°ç‰©SCG3ä¹Ÿåœ¨ä¸€éƒ¨åˆ†æ‚£è€…ä¸­å‡é«˜ã€‚ä¸å…¶ä»–ç ”ç©¶ä¸€è‡´çš„æ˜¯ï¼Œè¿™é¡¹ç ”ç©¶å‘ç°å‘ç°Long COVIDæ‚£è€…å…·æœ‰æŒç»­å‡é«˜çš„SARS-CoV-2æŠ—ä½“IgGï¼Œä½†è¿™äº›æ‚£è€…çš„ç—°æ¶²ä¸­å¹¶æ²¡æœ‰ç—…æ¯’RNA &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9lt5cvOc">æˆ‘æœ€å–œæ¬¢çš„æ ¡å›­å‰§ä¹‹ä¸€ - Heartbreak Highç¬¬äºŒå­£ä»Šå¤©ä¸Šçº¿äº†ã€‚çœ‹åˆ°å®ƒNetflixä¸Šçº¿æˆ‘å–œå‡ºæœ›å¤–ï¼Œæˆ‘å¯ä»¥æ˜å¤©ä¸‹ç­åä¸€ä¸‹æŠŠå®ƒçœ‹å®Œã€‚ - è½¬å‘ @å­é™µåœ¨å¬æ­Œ:&amp;ensp;ä¸€å£æ°”çœ‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9lt5cvoc/">
    
    
    
    
    
      
    
    æˆ‘æœ€å–œæ¬¢çš„æ ¡å›­å‰§ä¹‹ä¸€ - Heartbreak Highç¬¬äºŒå­£ä»Šå¤©ä¸Šçº¿äº†ã€‚çœ‹åˆ°å®ƒNetflixä¸Šçº¿æˆ‘å–œå‡ºæœ›å¤–ï¼Œæˆ‘å¯ä»¥æ˜å¤©ä¸‹ç­åä¸€ä¸‹æŠŠå®ƒçœ‹å®Œã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å­é™µåœ¨å¬æ­Œ<!-- raw HTML omitted -->:â€‚ä¸€å£æ°”çœ‹å®Œäº†Netflixçš„Heartbreak Highï¼Œè¿™éƒ¨æ¾³å¤§åˆ©äºšè½»å–œå‰§æ¯”åŒæ ·è¯é¢˜çš„è‹±å‰§Sex Educationæ›´åŠ è‡ªç„¶ï¼ŒçœŸè¯šå’Œå¿«ä¹ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9m9qwwKX">å¦‚æœä¸€ä¸ªABCå¯¹æˆ‘å¾ˆmeanï¼Œæˆ‘ä¼šè§‚å¯Ÿä¸€ä¸‹ä»–/å¥¹å¯¹ç™½äººçš„æ€åº¦ã€‚å¦‚æœä¸€æ ·ï¼Œè¯´æ˜ä»–/å¥¹åªæ˜¯crankyï¼›å¦‚æœå¾ˆä¸ä¸€æ ·ï¼Œæˆ‘è™½ç„¶å¾ˆä¸æ„¿æ„è¿™ä¹ˆæƒ³ï¼Œä½†æˆ‘ä¼šè§‰å¾—è¿™æ˜¯racially motiva...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9m9qwwkx/">
    
    
    
    
    
      
    
    å¦‚æœä¸€ä¸ªABCå¯¹æˆ‘å¾ˆmeanï¼Œæˆ‘ä¼šè§‚å¯Ÿä¸€ä¸‹ä»–/å¥¹å¯¹ç™½äººçš„æ€åº¦ã€‚å¦‚æœä¸€æ ·ï¼Œè¯´æ˜ä»–/å¥¹åªæ˜¯crankyï¼›å¦‚æœå¾ˆä¸ä¸€æ ·ï¼Œæˆ‘è™½ç„¶å¾ˆä¸æ„¿æ„è¿™ä¹ˆæƒ³ï¼Œä½†æˆ‘ä¼šè§‰å¾—è¿™æ˜¯racially motivatedã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9nAw8sXB">æˆ‘æœ€è¿‘åšäº†äº›æµ‹è¯•ï¼Œæ¯”è¾ƒä¸‰ä¸ªAI chatbot - ChatGPT, Google Geminiå’ŒCopilotï¼Œå°¤å…¶æ˜¯é’ˆå¯¹ä¸€äº›å…·ä½“é—®é¢˜çš„æ„è§å’Œå»ºè®®ã€‚ç»™æˆ‘æ„Ÿè§‰ChatGPTæœ€ç²—ç³™æœ€ä¸specificï¼›Gemini...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9naw8sxb/">
    
    
    
    
    
      
    
    æˆ‘æœ€è¿‘åšäº†äº›æµ‹è¯•ï¼Œæ¯”è¾ƒä¸‰ä¸ªAI chatbot - ChatGPT, Google Geminiå’ŒCopilotï¼Œå°¤å…¶æ˜¯é’ˆå¯¹ä¸€äº›å…·ä½“é—®é¢˜çš„æ„è§å’Œå»ºè®®ã€‚ç»™æˆ‘æ„Ÿè§‰ChatGPTæœ€ç²—ç³™æœ€ä¸specificï¼›Geminiå±…ä¸­ï¼›Copilotæœ€å¥½ã€‚Copilotæ¯ä¸ªå›ç­”éƒ½ååˆ†å…·ä½“ï¼Œè€Œä¸”éƒ½åˆ—å‡ºäº†å¼•ç”¨å’Œå‡ºå¤„ï¼Œå¯ä»¥fact checkã€‚ä¾‹å¦‚ï¼Œæˆ‘é—®äº†ä¸‰ä¸ªAI chatbotå¦‚ä¸‹åŒä¸€ä¸ªé—®é¢˜ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/4a994b1dgy1hoo2qsoobsj214x4df">https://tvax1.sinaimg.cn/large/4a994b1dgy1hoo2qsoobsj214x4df</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O9tFZqv1X">åšåŸºç¡€ç ”ç©¶çš„ç§‘å­¦å®¶å’Œä¸´åºŠåŒ»ç”Ÿå…·æœ‰ä¸åŒçš„æ€ç»´æ–¹å¼ï¼›è€Œå¾ˆå¤šé‡å¤§ç§‘å­¦çªç ´é ç›´è§‰è€Œä¸é è¯æ®ã€‚ä¸­åˆåƒé¥­ï¼Œè·ŸHarvard virology PhD programæ¯•ä¸šçš„åŒäº‹èŠå¤©ï¼Œå¥¹è®²äº†å‡ ä¸ª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o9tfzqv1x/">
    
    
    
    
    
      
    
    åšåŸºç¡€ç ”ç©¶çš„ç§‘å­¦å®¶å’Œä¸´åºŠåŒ»ç”Ÿå…·æœ‰ä¸åŒçš„æ€ç»´æ–¹å¼ï¼›è€Œå¾ˆå¤šé‡å¤§ç§‘å­¦çªç ´é ç›´è§‰è€Œä¸é è¯æ®ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸­åˆåƒé¥­ï¼Œè·ŸHarvard virology PhD programæ¯•ä¸šçš„åŒäº‹èŠå¤©ï¼Œå¥¹è®²äº†å‡ ä¸ªHarvard virologyçš„å¤§ç‰›éƒ½ä¸ä¼šå»å¬åŒè¡Œseminarï¼Œä¹Ÿä¸ä¼šè¯»åŒè¡Œçš„ç ”ç©¶è®ºæ–‡ï¼Œå› ä¸ºä»–ä»¬æ€•contaminationï¼ˆæ€•è¢«åŒé¢†åŸŸäººå£«çš„ç ”ç©¶ç»“è®ºå¹²æ‰°ï¼Œä»è€Œä¸å¾—ä¸æ”¹å˜è‡ªå·±çš„æƒ³æ³•ï¼‰ã€‚è¿™è·Ÿæˆ‘çš„è§‚å¯Ÿä¸€è‡´ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¯šç„¶ç”Ÿç‰©ç§‘å­¦åŸºç¡€ç ”ç©¶å’Œç°ä»£åŒ»å­¦æœ‰æ— æ•°äº¤å‰ï¼Œç°åœ¨å·²ç»æ˜¯ä½ ä¸­æœ‰æˆ‘ã€æˆ‘ä¸­æœ‰ä½ ï¼›ä½†éå¸¸ä¸åŒçš„ä¸€ç‚¹æ˜¯ï¼Œå¾ˆå¤šç”Ÿç‰©PhDè¶…çº§å¤§ç‰›ä»¬éƒ½éå¸¸ä¸å¾ªè¯ï¼ˆevidence based/fact checkedï¼‰ã€‚ä¸å°‘è¶…çº§å¤§ç‰›æ˜¯é ç›´è§‰ï¼ˆhunchï¼‰ã€è€Œä¸é åˆ†æç»¼åˆ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qPC0gtU">ğŸ”»å²¸ç”°å‘¨å››åœ¨ç¾å›½å›½ä¼šçš„è®²è¯æ ¸å¿ƒéƒ¨åˆ†æ˜¯ï¼šâ€œæˆ‘ä»¬ä»Šå¤©åœ¨è¿™é‡Œä¼šé¢æ—¶ï¼Œæˆ‘å¯Ÿè§‰åˆ°ä¸€äº›ç¾å›½äººå¯¹ä½ ä»¬åœ¨ä¸–ç•Œä¸Šåº”è¯¥æ‰®æ¼”ä»€ä¹ˆè§’è‰²æœ‰ä¸€ç§è‡ªæˆ‘æ€€ç–‘çš„æš—æµï¼Œç¾å›½å‡ ä»£äººåŠªåŠ›å»º...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qpc0gtu/">
    
    
    
    
    
      
    
    ğŸ”»å²¸ç”°å‘¨å››åœ¨ç¾å›½å›½ä¼šçš„è®²è¯æ ¸å¿ƒéƒ¨åˆ†æ˜¯ï¼šâ€œæˆ‘ä»¬ä»Šå¤©åœ¨è¿™é‡Œä¼šé¢æ—¶ï¼Œæˆ‘å¯Ÿè§‰åˆ°ä¸€äº›ç¾å›½äººå¯¹ä½ ä»¬åœ¨ä¸–ç•Œä¸Šåº”è¯¥æ‰®æ¼”ä»€ä¹ˆè§’è‰²æœ‰ä¸€ç§è‡ªæˆ‘æ€€ç–‘çš„æš—æµï¼Œç¾å›½å‡ ä»£äººåŠªåŠ›å»ºç«‹èµ·æ¥çš„å›½é™…ç§©åºæ­£é¢ä¸´ç€æ–°çš„æŒ‘æˆ˜ï¼Œè¿™äº›æŒ‘æˆ˜æ¥è‡ªé‚£äº›ä»·å€¼è§‚å’ŒåŸåˆ™ä¸æˆ‘ä»¬æˆªç„¶ä¸åŒçš„å›½å®¶ã€‚æˆ‘ç†è§£ä½œä¸ºä¸€ä¸ªå‡ ä¹ä»¥ä¸€å·±ä¹‹åŠ›ç»´æŠ¤å›½é™…ç§©åºçš„å›½å®¶çš„ç–²æƒ«ï¼Œä½†æ˜¯ç¾å›½çš„é¢†å¯¼ä½œç”¨ä¸å¯æˆ–ç¼ºã€‚å¦‚æœæ²¡æœ‰ç¾å›½çš„æ”¯æŒï¼Œä¹Œå…‹å…°çš„å¸Œæœ›è¿˜èƒ½ç»´æŒå¤šä¹…å°±ä¼šåœ¨è«æ–¯ç§‘çš„æ”»å‡»ä¸‹å´©æºƒï¼Ÿå¦‚æœæ²¡æœ‰ç¾å›½çš„å­˜åœ¨ï¼Œå°å¤ªè¿˜æœ‰å¤šä¹…å°±è¦é¢ä¸´æ›´åŠ ä¸¥å³»çš„ç°å®ï¼Ÿå¿…è¦æ—¶ï¼Œç¾å›½åšå‡ºäº†å´‡é«˜çš„ç‰º ç‰²ï¼Œä»¥å±¥è¡Œå…¶å¯¹æ›´ç¾å¥½ä¸–ç•Œçš„æ‰¿è¯ºã€‚â€ï¼ˆè‹±æ–‡ç‰ˆè¯‘æ–‡æ¥è‡ªå«æŠ¥ï¼‰<!-- raw HTML omitted -->ğŸ”»ç¾å›½äººç¿»å¼€å†å²ä¸€æŸ¥ï¼Œæ­ªæ­ªæ–œæ–œçš„æ¯é¡µä¸Šéƒ½å†™ç€â€œå´‡ é«˜ æ‰¿ è¯ºã€ä¸– ç•Œ é¢† è¢–â€å…«ä¸ªå­—ã€‚æ¨ªç«–ç¡ä¸ç€ï¼Œä»”ç»†çœ‹äº†åŠå¤œï¼Œæ‰ä»å­—ç¼é‡Œçœ‹å‡ºå­—æ¥ï¼Œæ»¡æœ¬éƒ½å†™ç€å››ä¸ªå­—æ˜¯â€œç¾ å›½ ç‰º &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qPSkMz7">ğŸ”»ç°åœ¨å°±ä¸Šçƒ­ä¸€å—ï¼ŸğŸ”»è¦æ˜¯å‘¨æœ«åˆæ²¡æ‰“æ€ä¹ˆåŠã€‚#ä¼Šæœ—#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qpskmz7/">
    
    
    
    
    
      
    
    ğŸ”»ç°åœ¨å°±ä¸Šçƒ­ä¸€å—ï¼Ÿ<!-- raw HTML omitted -->ğŸ”»è¦æ˜¯å‘¨æœ«åˆæ²¡æ‰“æ€ä¹ˆåŠã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¼Šæœ—#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qRFr1PM">ä¸æ„Ÿå…´è¶£ï¼ŒTD//@è¶…è¯ç¤¾åŒº:ä½ å¥½ï¼Œä½ æ„Ÿå…´è¶£çš„â€œä¼Šæœ—â€å·²å¼€é€šäº†è¶…è¯ç¤¾åŒºï½ è¶…è¯ç¤¾åŒºæ˜¯å¾®åšæ——ä¸‹å…´è¶£äº’åŠ¨ç¤¾åŒºï¼Œå¿«æ¥ä¸å¿—åŒé“åˆçš„å°ä¼™ä¼´ä»¬ä¸€èµ·äº¤æµäº’åŠ¨å§ï¼ æˆ³æˆ‘è¿›å…¥&gt;&gt;...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qrfr1pm/">
    
    
    
    
    
      
    
    ä¸æ„Ÿå…´è¶£ï¼ŒTD//<!-- raw HTML omitted -->@è¶…è¯ç¤¾åŒº<!-- raw HTML omitted -->:ä½ å¥½ï¼Œä½ æ„Ÿå…´è¶£çš„â€œä¼Šæœ—â€å·²å¼€é€šäº†è¶…è¯ç¤¾åŒºï½ è¶…è¯ç¤¾åŒºæ˜¯å¾®åšæ——ä¸‹å…´è¶£äº’åŠ¨ç¤¾åŒºï¼Œå¿«æ¥ä¸å¿—åŒé“åˆçš„å°ä¼™ä¼´ä»¬ä¸€èµ·äº¤æµäº’åŠ¨å§ï¼ æˆ³æˆ‘è¿›å…¥&gt;&gt; <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¼Šæœ—<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> -  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qRnqEly">ğŸ”»â€¦â€¦çœŸçš„å‡çš„ï¼Œè¿™æ ·å¯¹è€³æœµæœ‰å®³å§ï¼Ÿ[è´¹è§£]ğŸ”»æºï¼šVK / memelabel åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qrnqely/">
    
    
    
    
    
      
    
    ğŸ”»â€¦â€¦çœŸçš„å‡çš„ï¼Œè¿™æ ·å¯¹è€³æœµæœ‰å®³å§ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»æºï¼šVK / memelabel <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qS0cDUL">ğŸ”»ä¸è¦ç†¬å¤œå•Šå¤§å®¶ã€‚ğŸ”»ç†¬å¤œå¯¹èº«ä½“ä¸å¥½ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qs0cdul/">
    
    
    
    
    
      
    
    ğŸ”»ä¸è¦ç†¬å¤œå•Šå¤§å®¶ã€‚<!-- raw HTML omitted -->ğŸ”»ç†¬å¤œå¯¹èº«ä½“ä¸å¥½ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qWKcq7T">å¤©å¤§åœ°å¤§ä¼‘æ¯æœ€å¤§ï¼Œå¤§ç«ç®­å®åœ¨è¦æ‰“ä¹Ÿæ²¡æœ‰åŠæ³•ï¼Œè®©å®ƒæ‰“ã€‚//@å”å®æ°š:ä½†ï¼Œä¼Šæœ—çš„å¤§ç«ç®­ä¸èƒ½è¾œè² [æ‚²ä¼¤][doge] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ä¸è¦ç†¬å¤œå•Šå¤§å®¶ã€‚ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qwkcq7t/">
    
    
    
    
    
      
    
    å¤©å¤§åœ°å¤§ä¼‘æ¯æœ€å¤§ï¼Œå¤§ç«ç®­å®åœ¨è¦æ‰“ä¹Ÿæ²¡æœ‰åŠæ³•ï¼Œè®©å®ƒæ‰“ã€‚//<!-- raw HTML omitted -->@å”å®æ°š<!-- raw HTML omitted -->:ä½†ï¼Œä¼Šæœ—çš„å¤§ç«ç®­ä¸èƒ½è¾œè² <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a href=&ldquo;<a href="https://weibo.com/1671109627%22">https://weibo.com/1671109627&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9qYJ5JnG">ğŸ”»ç¾å›½å®˜å‘˜å‘Šè¯‰ al jazeeraï¼šâ€œæˆ‘ä»¬ç»§ç»­ç›‘æµ‹ä¼Šæœ—ä¸ºå¯èƒ½æ”»å‡»ä»¥è‰²åˆ—è€Œè°ƒåŠ¨å†›äº‹èƒ½åŠ›çš„æƒ…å†µï¼Œä¼Šæœ—æ­£åœ¨è°ƒåŠ¨çš„å†›äº‹åŠ›é‡åŒ…æ‹¬å¤§é‡æ— äººæœºéƒ¨é˜Ÿã€‚æˆ‘ä»¬ä¸å¯»æ±‚ä¸ä¼Šæœ—çš„å†²çª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9qyj5jng/">
    
    
    
    
    
      
    
    ğŸ”»ç¾å›½å®˜å‘˜å‘Šè¯‰ al jazeeraï¼šâ€œæˆ‘ä»¬ç»§ç»­ç›‘æµ‹ä¼Šæœ—ä¸ºå¯èƒ½æ”»å‡»ä»¥è‰²åˆ—è€Œè°ƒåŠ¨å†›äº‹èƒ½åŠ›çš„æƒ…å†µï¼Œä¼Šæœ—æ­£åœ¨è°ƒåŠ¨çš„å†›äº‹åŠ›é‡åŒ…æ‹¬å¤§é‡æ— äººæœºéƒ¨é˜Ÿã€‚æˆ‘ä»¬ä¸å¯»æ±‚ä¸ä¼Šæœ—çš„å†²çªå‡çº§ï¼Œä½†æˆ‘ä»¬å°†ä¿æŠ¤æˆ‘ä»¬çš„éƒ¨é˜Ÿï¼Œæˆ‘ä»¬å¯¹ä»¥è‰²åˆ—å®‰å…¨çš„æ‰¿è¯ºæ˜¯åšå®šä¸ç§»çš„ã€‚â€<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¼Šæœ—#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9rsOx6vC">ğŸ”»è§†é¢‘1ï¼šä¼Šæœ—åŸå¸‚åº“å§†ä¸Šç©ºã€‚ğŸ”»è§†é¢‘2ï¼šä¼Šæ‹‰å…‹åŸå¸‚è¾›è´¾å°”ä¸Šç©ºã€‚ğŸ”»è§†é¢‘3ï¼šä¿„ç½—æ–¯åŸå¸‚é˜¿æ–¯ç‰¹æ‹‰ç½•ä¸Šç©ºã€‚ğŸ”»æ®ä¿„ç½—æ–¯å›½é˜²éƒ¨ç§°ï¼Œè§†é¢‘3æ˜¯ä¿„å†›åœ¨å¡æ™®æ–¯äº¬äºšå°”è¯•éªŒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9rsox6vc/">
    
    
    
    
    
      
    
    ğŸ”»è§†é¢‘1ï¼šä¼Šæœ—åŸå¸‚åº“å§†ä¸Šç©ºã€‚<!-- raw HTML omitted -->ğŸ”»è§†é¢‘2ï¼šä¼Šæ‹‰å…‹åŸå¸‚è¾›è´¾å°”ä¸Šç©ºã€‚<!-- raw HTML omitted -->ğŸ”»è§†é¢‘3ï¼šä¿„ç½—æ–¯åŸå¸‚é˜¿æ–¯ç‰¹æ‹‰ç½•ä¸Šç©ºã€‚<!-- raw HTML omitted -->ğŸ”»æ®ä¿„ç½—æ–¯å›½é˜²éƒ¨ç§°ï¼Œè§†é¢‘3æ˜¯ä¿„å†›åœ¨å¡æ™®æ–¯äº¬äºšå°”è¯•éªŒåœºåˆšåˆšæˆåŠŸè¯•å°„äº†ä¸€æšæ´²é™…å¼¹é“å¯¼å¼¹ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸çŸ¥è§†é¢‘1-2ä¸è§†é¢‘3æ˜¯å¦æœ‰å…³ç³»ã€‚<!-- raw HTML omitted -->ğŸ”»è§†é¢‘æ¥æºäºä¿„åª’Bazaå’Œä¿„ç½—æ–¯å›½é˜²éƒ¨åœ¨ VK å®˜æ–¹è´¦å·ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¼Šæœ—#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9rup0AXH">ğŸ”»é»å·´å«©çœŸä¸»å…šæ­¦è£…è¿™ä¼šå„¿æ­£åœ¨å¾€ä»¥è‰²åˆ—çš„ä¸ŠåŠ åˆ©åˆ©æ‰“åœŸç«ç®­ï¼Œä¸€å£æ°”æ‰“äº†äº”åå¤šå‘ã€‚ğŸ”»ä¸æ’é™¤æ˜¯åœ¨â€œæ¼«é•¿çš„48å°æ—¶â€ä¸­ï¼Œé¦–å…ˆç»™é“ç©¹ä¸Šç‚¹å¼ºåº¦ã€‚ğŸ”»æ±‡æ€»æºï¼šVK.com...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9rup0axh/">
    
    
    
    
    
      
    
    ğŸ”»é»å·´å«©çœŸä¸»å…šæ­¦è£…è¿™ä¼šå„¿æ­£åœ¨å¾€ä»¥è‰²åˆ—çš„ä¸ŠåŠ åˆ©åˆ©æ‰“åœŸç«ç®­ï¼Œä¸€å£æ°”æ‰“äº†äº”åå¤šå‘ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸æ’é™¤æ˜¯åœ¨â€œæ¼«é•¿çš„48å°æ—¶â€ä¸­ï¼Œé¦–å…ˆç»™é“ç©¹ä¸Šç‚¹å¼ºåº¦ã€‚<!-- raw HTML omitted -->ğŸ”»æ±‡æ€»æºï¼šVK.com ä¸Šçš„ ĞŸĞ¾Ñ€Ñ‚Ñ„ĞµĞ»ÑŒ Ğ“ĞµĞ½ÑˆÑ‚Ğ°Ğ±Ğ°ã€‚<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¼Šæœ—#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hoojz4uy1jj20cy">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hoojz4uy1jj20cy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O9rzozkSG">ğŸ”»ä»ä¿„ç½—æ–¯äººæ‹æ‘„çš„è§†é¢‘æ¥çœ‹ï¼Œç–‘ä¼¼ä¼Šæœ—å’Œä¼Šæ‹‰å…‹åŸå¸‚ä¸Šç©ºçœ‹åˆ°çš„æ°´æ¯çŠ¶é£è¡Œç—•è¿¹ï¼Œå°±æ˜¯ä¿„å†›åœ¨å¡æ™®æ–¯äº¬äºšå°”è¯•éªŒåœºåˆšåˆšæˆåŠŸè¯•å°„çš„æ´²é™…å¯¼å¼¹ã€‚ğŸ”»æºï¼šĞšĞ¾Ğ¼Ğ¼ĞµÑ€Ñ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o9rzozksg/">
    
    
    
    
    
      
    
    ğŸ”»ä»ä¿„ç½—æ–¯äººæ‹æ‘„çš„è§†é¢‘æ¥çœ‹ï¼Œç–‘ä¼¼ä¼Šæœ—å’Œä¼Šæ‹‰å…‹åŸå¸‚ä¸Šç©ºçœ‹åˆ°çš„æ°´æ¯çŠ¶é£è¡Œç—•è¿¹ï¼Œå°±æ˜¯ä¿„å†›åœ¨å¡æ™®æ–¯äº¬äºšå°”è¯•éªŒåœºåˆšåˆšæˆåŠŸè¯•å°„çš„æ´²é™…å¯¼å¼¹ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šĞšĞ¾Ğ¼Ğ¼ĞµÑ€ÑĞ°Ğ½Ñ‚ÑŠ / VK<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ï¼Œé´å­æ²¡æœ‰è½åœ°ï¼Œå‘¨æœ«æ„‰å¿«ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¼Šæœ—#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/O9l6f78px">[æ˜¥æ¸¸å®¶æ—][æ˜¥æ¸¸å®¶æ—][æ˜¥æ¸¸å®¶æ—] - è½¬å‘ @Lotte-F:&amp;ensp;ğŸ“·ç™½å®¢ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-o9l6f78px/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[æ˜¥æ¸¸å®¶æ—]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/b6/2021_YoungFamily_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/b6/2021_YoungFamily_org.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; referrerpolicy=&ldquo;no-referrer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/O9qeTpbO1">æˆ‘çš„æ€åº¦ï¼š [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-o9qetpbo1/">
    
    
    
    
    
      
    
    æˆ‘çš„æ€åº¦ï¼š <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9m4dvX31">ç«-ç­å™¨-å“­ç”µ-ç”°ğŸ‘¿æ™ºåŠ›ä¹Ÿå°±è¿™ä¹ˆå¤šäº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9m4dvx31/">
    
    
    
    
    
      
    
    ç«-ç­<!-- raw HTML omitted -->å™¨-å“­<!-- raw HTML omitted -->ç”µ-ç”°<!-- raw HTML omitted -->ğŸ‘¿æ™ºåŠ›ä¹Ÿå°±è¿™ä¹ˆå¤šäº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9m9wsgoj">åˆ°å®åœ°å‡ºå·®æœ€å¤§çš„å¹¸ç¦å°±æ˜¯åˆé¤[doge] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9m9wsgoj/">
    
    
    
    
    
      
    
    åˆ°å®åœ°å‡ºå·®æœ€å¤§çš„å¹¸ç¦å°±æ˜¯åˆé¤<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9mnipuKu">è¿™æ®µæ§½ç‚¹å®åœ¨æ˜¯å¤šå¦‚ç‰›æ¯›ğŸ‘¿ğŸ‘¿ğŸ‘¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9mnipuku/">
    
    
    
    
    
      
    
    è¿™æ®µæ§½ç‚¹å®åœ¨æ˜¯å¤šå¦‚ç‰›æ¯›ğŸ‘¿ğŸ‘¿ğŸ‘¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9mYS2ZKQ">å›é¡¾ä¸€ç›˜16å¹´å‰çš„è€å¯¹å±€ï¼ŒæçŸçœŸå‹‡å¤ºä¸–ç•Œäºšå†›ã€‚å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šè‡è¯´å…«é“ï¼ˆæ™®é€šç‰ˆNo.136ï¼‰ï¼šç®—ä½ å‰å®³ã€‹ è‡è¯´å…«é“ï¼ˆæ™®é€šç‰ˆNo.136ï¼‰ï¼šç®—ä½ å‰å®³ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9mys2zkq/">
    
    
    
    
    
      
    
    å›é¡¾ä¸€ç›˜16å¹´å‰çš„è€å¯¹å±€ï¼ŒæçŸçœŸå‹‡å¤ºä¸–ç•Œäºšå†›ã€‚å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šè‡è¯´å…«é“ï¼ˆæ™®é€šç‰ˆNo.136ï¼‰ï¼šç®—ä½ å‰å®³ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è‡è¯´å…«é“ï¼ˆæ™®é€šç‰ˆNo.136ï¼‰ï¼šç®—ä½ å‰å®³<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9nl40yS4">å­¦åˆ°äº†ï¼Œintå’Œflooræ˜¯TMä¸¤ä¸ªå‡½æ•°</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9nl40ys4/">
    
    
    
    
    
      
    
    å­¦åˆ°äº†ï¼Œintå’Œflooræ˜¯TMä¸¤ä¸ªå‡½æ•°  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9nLxzyfd">è¿™æ˜¯éå¸¸æœ‰è‰¯å¿ƒçš„æŠ½ç­¾ï¼Œå¿…å®šæœ‰ä¸€äººèƒ½æ™‹çº§ã€‚ - è½¬å‘ @æˆ‘çš„IDå°†å¦‚æ ‘æ‡’èˆ¬å½’æ¥:&amp;ensp;ä»”ç»†æƒ³æƒ³èŠˆæŸ¯å¦‚æœä¸èƒ½å‡ºçº¿æ˜¯æœ‰ç‚¹åœ°ç‹±ï¼Œæ›´åœ°ç‹±çš„åœºæ™¯å¯èƒ½æ˜¯ä»–ä¿©ä¸‹ä¸€è½®æŠ½åˆ°ä¸€èµ·[...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9nlxzyfd/">
    
    
    
    
    
      
    
    è¿™æ˜¯éå¸¸æœ‰è‰¯å¿ƒçš„æŠ½ç­¾ï¼Œå¿…å®šæœ‰ä¸€äººèƒ½æ™‹çº§ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æˆ‘çš„IDå°†å¦‚æ ‘æ‡’èˆ¬å½’æ¥<!-- raw HTML omitted -->:â€‚ä»”ç»†æƒ³æƒ³èŠˆæŸ¯å¦‚æœä¸èƒ½å‡ºçº¿æ˜¯æœ‰ç‚¹åœ°ç‹±ï¼Œæ›´åœ°ç‹±çš„åœºæ™¯å¯èƒ½æ˜¯ä»–ä¿©ä¸‹ä¸€è½®æŠ½åˆ°ä¸€èµ·<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9oT8erCG">å¤§è€çˆ·ç”¨æ‰‹æŒ‡åœ¨ä¸Šé¢æ‹¼ä¸€æ¨ªçº¿ï¼Œè¯´è¿™æ˜¯â€œç®±â€ğŸ‘¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9ot8ercg/">
    
    
    
    
    
      
    
    å¤§è€çˆ·ç”¨æ‰‹æŒ‡åœ¨ä¸Šé¢æ‹¼ä¸€æ¨ªçº¿ï¼Œè¯´è¿™æ˜¯â€œç®±â€ğŸ‘¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O9oz3qvUQ">ç ´æ¡ˆäº†ï¼Œä¸€åˆ‡éƒ½æ˜¯æ¨¡æ¿[ç¬‘å“ˆå“ˆ] - è½¬å‘ @vvvwwwvvvwwe:&amp;ensp;åˆ†äº«å›¾ç‰‡ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o9oz3qvuq/">
    
    
    
    
    
      
    
    ç ´æ¡ˆäº†ï¼Œä¸€åˆ‡éƒ½æ˜¯æ¨¡æ¿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@vvvwwwvvvwwe<!-- raw HTML omitted -->:â€‚åˆ†äº«å›¾ç‰‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9n7Qc6DH">è½¬å‘å¾®åš - è½¬å‘ @æ¢¨çªä¸¸:&amp;ensp;æ±äº¬ã‚«ãƒ¬ãƒ³ãƒ€ãƒ¼TokyoCalendar è¥¿é‡ä¸ƒç€¬ ã€è¥¿é‡ä¸ƒç€¬ ã•ã‚“ã€ç¾ã—ã„æ–™ç†ã«ç¬‘é¡”ğŸ’• ËËŠË—ã€‘æ’®å½±ã§ã¯ã€ç¾ã—ã„æ–™ç†ã®æ•°ã€…ã«èˆŒé¼“ã‚’æ‰“...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9n7qc6dh/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ¢¨çªä¸¸<!-- raw HTML omitted -->:â€‚æ±äº¬ã‚«ãƒ¬ãƒ³ãƒ€ãƒ¼TokyoCalendar <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¥¿é‡ä¸ƒç€¬<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->ã€è¥¿é‡ä¸ƒç€¬ ã•ã‚“ã€ç¾ã—ã„æ–™ç†ã«ç¬‘é¡”ğŸ’• ËËŠË—ã€‘<!-- raw HTML omitted --><!-- raw HTML omitted -->æ’®å½±ã§ã¯ã€ç¾ã—ã„æ–™ç†ã®æ•°ã€…ã«èˆŒé¼“ã‚’æ‰“ã¤è¥¿é‡ã•ã‚“ï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->ãã®ç¾ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9nH768F2">è½¬å‘å¾®åš - è½¬å‘ @YodaChannel:&amp;ensp;ä¸ç”°ç¥å¸Œ #ä¸ç”°ç¥å¸Œ# 2024.04.12 15:05æœ‰å‘è¿‡å—ï¼Ÿè¿™ä¸ªè§†é¢‘ï¼ YodaChannelçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9nh768f2/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@YodaChannel<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸ç”°ç¥å¸Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%8E%E7%94%B0%E7%A5%90%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%8E%E7%94%B0%E7%A5%90%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9pjIlVel">æ²¡ç‚¹å¼€å‰ä»¥ä¸ºåœ¨æ·˜ç±³ï¼Œæ‰‹æ³•è·Ÿæˆ‘ä¸€æ · - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia. ç·’è¡Œè®° ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9pjilvel/">
    
    
    
    
    
      
    
    æ²¡ç‚¹å¼€å‰ä»¥ä¸ºåœ¨æ·˜ç±³ï¼Œæ‰‹æ³•è·Ÿæˆ‘ä¸€æ ·<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via. ç·’è¡Œè®° ins &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5022419870744600%22">https://video.weibo.com/show?fid=1034:5022419870744600&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9pjoFEio">//@é¡¶ç­†TENä½¿:ä¹…ä¿å²ç»ªé‡Œ//@å±±ä¸‹ç¾æœˆæ•™ä¼š:å±±ä¸‹ç¾æœˆ - è½¬å‘ @YodaChannel:&amp;ensp;ä¸ç”°ç¥å¸Œ #ä¸ç”°ç¥å¸Œ# 2024.04.12 15:05æœ‰å‘è¿‡å—ï¼Ÿè¿™ä¸ªè§†é¢‘ï¼ YodaChannelçš„å¾®åšè§†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9pjofeio/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:&lt;a href=&ldquo;<a href="https://m.weibo.cn/">https://m.weibo.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9rWgoZxM">è¯›ä»™2å°Šå˜Ÿå¾ˆå¥½çœ‹ğŸ¥¹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9rwgozxm/">
    
    
    
    
    
      
    
    è¯›ä»™2å°Šå˜Ÿå¾ˆå¥½çœ‹ğŸ¥¹  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9rXZvTix">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.11 19:22(è¡¥)ã€Œç­‰å¾…ã€å¹¸ç¦æ˜¯ä¼šäº¤æ›¿åœ°åˆ°æ¥çš„ã€‚æœ‰æ—¶å€™èƒ½å¤Ÿå¾ˆå¥½åœ°ç†è§£è¿™ä¸€ç‚¹ä½†ä¹Ÿæœ‰æ—¶æ˜æ˜...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9rxzvtix/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9rY1nS4J">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä»Šæ™š25:20ï½ï¼ˆJSTï¼‰(è¡¥)ä¸œäº¬ç”µè§†ç½‘ã€æ—¥æœ¬æ€ªå¥‡ãƒ«ãƒãƒ«ã‚¿ãƒ¼ã‚¸ãƒ¥ã€æˆ‘ä¼šæ¥ç»­ä¸Šå‘¨å‡ºæ¼”ã€‚è¯·ä¸€å®šè¦çœ‹ğŸ’â™€ï¸...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9ry1ns4j/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%252">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9rY720lN">å¥½é¥¿å¥½é¥¿ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# (è¡¥)çœŸçš„â€¦æ˜¯ç°åœ¨æœ€æƒ³åƒçš„â€¦è™¾å­å¤©å¦‡ç½—ç›–é¥­â€¦ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9ry720ln/">
    
    
    
    
    
      
    
    å¥½é¥¿å¥½é¥¿<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9ssvqjvw">å¥½é¥¿å•ŠçœŸçš„å¥½é¥¿æ¯å¤©æ™šä¸Šéƒ½å¥½é¥¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9ssvqjvw/">
    
    
    
    
    
      
    
    å¥½é¥¿å•ŠçœŸçš„å¥½é¥¿æ¯å¤©æ™šä¸Šéƒ½å¥½é¥¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O9syMvCHE">åŒå¿ƒè¯çœŸçš„æ— æ•ŒğŸ˜­</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o9symvche/">
    
    
    
    
    
      
    
    åŒå¿ƒè¯çœŸçš„æ— æ•ŒğŸ˜­  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O9lFKeiyo">loveitå’²æœˆå¯æ„›ï¼æ–°åˆ¶æœå¥½çœ‹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o9lfkeiyo/">
    
    
    
    
    
      
    
    loveit<!-- raw HTML omitted -->å’²æœˆå¯æ„›ï¼æ–°åˆ¶æœå¥½çœ‹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O9nZL1Rnd">å°å‰å’Œloveitå¥³ä¸»æŒäºº#ç”°æ‘çœŸå­#éå¸¸åƒ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o9nzl1rnd/">
    
    
    
    
    
      
    
    å°å‰å’Œloveitå¥³ä¸»æŒäºº<!-- raw HTML omitted --><!-- raw HTML omitted -->#ç”°æ‘çœŸå­#<!-- raw HTML omitted --><!-- raw HTML omitted -->éå¸¸åƒ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/005TCz76gy1hoo4jaro2aj31400u0wkc.jpg%22">https://tvax1.sinaimg.cn/large/005TCz76gy1hoo4jaro2aj31400u0wkc.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O9nQVdrwP">æˆ‘è§‰å¾—è‡ªå·±å»å¹´å¼€å§‹æœ‰ä¸€ç‚¹â€œå¿ƒèº«è€—ç«­â€çš„ç—‡çŠ¶ä¹‹åï¼Œå¯¹å¾ˆå¤šç“œå·²ç»ä¸æ„Ÿå…´è¶£äº†ï¼Œæˆ–è€…è¯´çŸ¥é“ä¸€ä¸ªå¼€å¤´ï¼Œåé¢å•¥äº‹å„¿éƒ½æ— æ‰€è°“äº†ã€‚ä¸€æ–¹é¢å¾ˆæ¸…æ¥šè¿™äº›äº‹æƒ…ä¸æ˜¯æˆ‘å…³æ³¨äº†å°±å¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o9nqvdrwp/">
    
    
    
    
    
      
    
    æˆ‘è§‰å¾—è‡ªå·±å»å¹´å¼€å§‹æœ‰ä¸€ç‚¹â€œå¿ƒèº«è€—ç«­â€çš„ç—‡çŠ¶ä¹‹åï¼Œå¯¹å¾ˆå¤šç“œå·²ç»ä¸æ„Ÿå…´è¶£äº†ï¼Œæˆ–è€…è¯´çŸ¥é“ä¸€ä¸ªå¼€å¤´ï¼Œåé¢å•¥äº‹å„¿éƒ½æ— æ‰€è°“äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸€æ–¹é¢å¾ˆæ¸…æ¥šè¿™äº›äº‹æƒ…ä¸æ˜¯æˆ‘å…³æ³¨äº†å°±å¯ä»¥æœ‰å†³å®šæ€§å˜åŒ–çš„äº‹æƒ…ï¼Œå¯¹ä»»ä½•ç“œè®¨è®ºå’Œäº‰è®ºå°±æ˜¯æµªè´¹æ—¶é—´è€Œå·²ï¼Œæˆ‘æ¯”é‚£å¸®äººå¿™å¤šäº†ï¼Œæ²¡æ—¶é—´çœ‹è¿™äº›æ²¡è¥å…»çš„äº‹æƒ…ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ„Ÿè§‰å¾ˆå¤šäº‹æƒ…ä¸å…¶â€œç­”è¾©èˆ¬çš„â€˜ä¾¿â€™è®ºâ€ï¼Œä¸å¦‚ç›´æ¥å»é—®å½“äº‹äººæ¥é¾™å»è„‰ï¼Œå¦‚æœé—®ä¸åˆ°å°±åšå‡æ³•ä¸å…³å¿ƒä¸å…³æ³¨å°±è¡Œäº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å½“ç„¶è§‰å¾—å®åœ¨æ˜¯å¤ªé—²äº†æƒ³æ¶ˆç£¨ä¸€ä¸‹ç”Ÿå‘½ä¹Ÿæ²¡é—®é¢˜ã€‚è‡³å°‘æˆ‘æ˜¯è¿™æ ·çš„å°¿æ€§ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%25A">https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O9qYNnMuF">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šäº•å±±è£•å¤ªï¼šåšæŒè‡ªå·±çš„ä¿¡å¿µï¼Œä¸‹å‡ºå±äºäº•å±±è£•å¤ªçš„æ£‹å±€ã€‹ #å›´æ£‹# å›´æ£‹ äº•å±±è£•å¤ªï¼šåšæŒè‡ªå·±çš„ä¿¡å¿µï¼Œä¸‹å‡ºå±äºäº•å±±è£•å¤ªçš„æ£‹å±€ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o9qynnmuf/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šäº•å±±è£•å¤ªï¼šåšæŒè‡ªå·±çš„ä¿¡å¿µï¼Œä¸‹å‡ºå±äºäº•å±±è£•å¤ªçš„æ£‹å±€ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9nJB29kQ">ä¹…ä¿å²ç»ªé‡Œ//@å±±ä¸‹ç¾æœˆæ•™ä¼š:å±±ä¸‹ç¾æœˆ - è½¬å‘ @YodaChannel:&amp;ensp;ä¸ç”°ç¥å¸Œ #ä¸ç”°ç¥å¸Œ# 2024.04.12 15:05æœ‰å‘è¿‡å—ï¼Ÿè¿™ä¸ªè§†é¢‘ï¼ YodaChannelçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9njb29kq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080">https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9pfsCb8G">ä¹…ä¿å²ç»ªé‡Œvia. ç·’è¡Œè®° ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9pfscb8g/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via. ç·’è¡Œè®° ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/tim">https://h5.sinaimg.cn/upload/2015/09/25/3/tim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9r2GdpVc">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.11 19:22(è¡¥)ã€Œç­‰å¾…ã€å¹¸ç¦æ˜¯ä¼šäº¤æ›¿åœ°åˆ°æ¥çš„ã€‚æœ‰æ—¶å€™èƒ½å¤Ÿå¾ˆå¥½åœ°ç†è§£è¿™ä¸€ç‚¹ä½†ä¹Ÿæœ‰æ—¶æ˜æ˜æ—©çŸ¥é“äº†å´æ— æ³•ç†è§£çš„æ—¶å€™ã€‚è‡ªå·±çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9r2gdpvc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9r2WEx1k">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä»Šæ™š25:20ï½ï¼ˆJSTï¼‰(è¡¥)ä¸œäº¬ç”µè§†ç½‘ã€æ—¥æœ¬æ€ªå¥‡ãƒ«ãƒãƒ«ã‚¿ãƒ¼ã‚¸ãƒ¥ã€æˆ‘ä¼šæ¥ç»­ä¸Šå‘¨å‡ºæ¼”ã€‚è¯·ä¸€å®šè¦çœ‹ğŸ’â™€ï¸æŠ±æ­‰ï¼Œåªå‘å‘æ–°æœè£…çš„ç…§ç‰‡ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9r2wex1k/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram# &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O9r3f04aI">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# (è¡¥)çœŸçš„â€¦æ˜¯ç°åœ¨æœ€æƒ³åƒçš„â€¦è™¾å­å¤©å¦‡ç½—ç›–é¥­â€¦ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o9r3f04ai/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O9oHOqJwV">æŸ¯æ´#æŸ¯æŸ¯æŠ–éŸ³åŠ¨æ€æ¬è¿# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o9ohoqjwv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1cD421W7TH">é™ˆç¿”å…­ç‚¹åŠï¼šé™ªä½ é£é£é›¨é›¨ï¼Œæ„¿ä½ ç¬‘å£å¸¸å¼€</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1cd421w7th/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/652616479/answer/3463315818">é‡å­ä½å›ç­”äº†é—®é¢˜: è¶…5æˆç¨‹åºå‘˜ç”¨AIå†™ä»£ç ï¼Œå¦‚ä½•çœ‹å¾…èš‚èšé˜¿é‡Œäº‘ç™¾åº¦ç­‰å¤§å‚æ¨è¡ŒAIç¼–ç¨‹ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-652616479-answer-3463315818/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/691770272">å¼ æ•¬ä¿¡èµåŒäº†æ–‡ç« : éçº¿æ€§é™ç»´ç®—æ³•-UMAP</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-691770272/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692152903">çŒ«å“¥çš„è§†ç•Œå‘è¡¨äº†æ–‡ç« : å¤§å›½ä¸æ˜¯åƒç´ çš„ï¼šä¸œå—äºšå››ç™¾å¹´åæ˜¯æ€æ ·å›åˆ°ä¸­å›½çš„æ€€æŠ±ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692152903/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692194794">é‡å­ä½å‘è¡¨äº†æ–‡ç« : é­”æ”¹RNNæŒ‘æˆ˜Transformerï¼ŒRWKVä¸Šæ–°ï¼šæ¨å‡º2ç§æ–°æ¶æ„æ¨¡å‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692194794/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692206051">é‡å­ä½å‘è¡¨äº†æ–‡ç« : GPT-4å‡çº§è¢«æ›å¼•å…¥Q*ï¼Œæ¨ç†/æ•°å­¦æ›´å¼ºåºŸè¯æ›´å°‘ï¼Œç«æŠ€åœºé‡å¤ºç‹ä½</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692206051/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/692209307">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è°·æ­Œçˆ†æ”¹Transformerï¼Œâ€œæ— é™æ³¨æ„åŠ›â€è®©1Bå°æ¨¡å‹è¯»å®Œ10éƒ¨å°è¯´ï¼Œ114å€ä¿¡æ¯å‹ç¼©</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-12</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-692209307/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

